Welcome to episode 163 of the Bodybuilding Down Under podcast!

In this episode, we start with a brief follow-up on GLP-1 agonists before diving into a larger discussion around emerging muscle-building pharmaceuticals such as Trevogrumab and Garetosmab. We explore how these new compounds differ from traditional anabolic steroids and SARMs, and what their development could mean for the future of natural bodybuilding.

We also introduce a fun new segment where we rate listener-submitted food combinations, and finish with a Q&A covering fat gain in the off-season, long-term motivation, and our early experiences with bodybuilding.

Topics covered include:

🔹 GLP-1 agonist update

As always, thank you for listening. If you’re enjoying the podcast, don’t forget to subscribe, leave a five-star review, and share it to your IG story so we can repost it.

Stay serious about it, and we’ll catch you in the next one.

Instagram Handles:

Bodybuilding Down Under: https://www.instagram.com/bodybuildingdownunder/

Jack: https://www.instagram.com/jack.radfordsmith/

Daniel C: https://www.instagram.com/daniel.chapelle/

Lawrence: https://www.instagram.com/general.muscle/

Daniel Y: https://www.instagram.com/dy.fit/